• Annals of surgery · Jan 2017

    Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.

    • Thomas W Rice, Hemant Ishwaran, Wayne L Hofstetter, Paul H Schipper, Kenneth A Kesler, Simon Law, E M R Lerut, Chadrick E Denlinger, Jarmo A Salo, Walter J Scott, Thomas J Watson, Mark S Allen, Long-Qi Chen, Valerie W Rusch, Robert J Cerfolio, James D Luketich, Andre Duranceau, Gail E Darling, Manuel Pera, Carolyn Apperson-Hansen, and Eugene H Blackstone.
    • *Cleveland Clinic, Cleveland, OH †University of Miami, Miami, FL ‡University of Texas, MD Anderson Cancer Center, Houston, TX §Oregon Health and Science Center, Portland, OR ¶Indiana University, Indianapolis, IN ||Queen Mary Hospital, The University of Hong Kong, People's Republic of China **University Hospital Leuven, Leuven, Belgium ††Medical University of South Carolina, Charleston, SC ‡‡Helsinki University Hospital, Helsinki, Finland §§Fox Chase Cancer Center, Philadelphia, PA ¶¶University of Rochester, Rochester, New York, NY ||||Mayo Clinic, Rochester, MN ***West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China †††Memorial Sloan-Kettering Cancer Center, New York, NY ‡‡‡University of Alabama at Birmingham, Birmingham, AL §§§University of Pittsburgh School of Medicine, Pittsburgh, PA ¶¶¶University of Montreal, Montreal, Canada ||||||Toronto General Hospital, Toronto, Canada ****Hospital Universitario del Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona, Barcelona, Spain.
    • Ann. Surg. 2017 Jan 1; 265 (1): 122-129.

    ObjectivesTo identify the associations of lymph node metastases (pN+), number of positive nodes, and pN subclassification with cancer, treatment, patient, geographic, and institutional variables, and to recommend extent of lymphadenectomy needed to accurately detect pN+ for esophageal cancer.Summary Background DataLimited data and traditional analytic techniques have precluded identifying intricate associations of pN+ with other cancer, treatment, and patient characteristics.MethodsData on 5806 esophagectomy patients from the Worldwide Esophageal Cancer Collaboration were analyzed by Random Forest machine learning techniques.ResultspN+, number of positive nodes, and pN subclassification were associated with increasing depth of cancer invasion (pT), increasing cancer length, decreasing cancer differentiation (G), and more regional lymph nodes resected. Lymphadenectomy necessary to accurately detect pN+ is 60 for shorter, well-differentiated cancers (<2.5 cm) and 20 for longer, poorly differentiated ones.ConclusionsIn esophageal cancer, pN+, increasing number of positive nodes, and increasing pN classification are associated with deeper invading, longer, and poorly differentiated cancers. Consequently, if the goal of lymphadenectomy is to accurately define pN+ status of such cancers, few nodes need to be removed. Conversely, superficial, shorter, and well-differentiated cancers require a more extensive lymphadenectomy to accurately define pN+ status.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.